Penumbra (PEN)
(Delayed Data from NYSE)
$234.36 USD
+12.21 (5.50%)
Updated Mar 18, 2024 04:00 PM ET
After-Market: $234.45 +0.09 (0.04%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth B Momentum B VGM
Income Statements
Fiscal Year end for Penumbra, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,059 | 847 | 748 | 560 | 547 |
Cost Of Goods | 376 | 312 | 272 | 222 | 175 |
Gross Profit | 683 | 535 | 475 | 338 | 372 |
Selling & Adminstrative & Depr. & Amort Expenses | 609 | 529 | 483 | 377 | 324 |
Income After Depreciation & Amortization | 74 | 6 | -8 | -39 | 48 |
Non-Operating Income | 6 | -2 | -3 | 1 | 3 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 80 | 4 | -11 | -38 | 50 |
Income Taxes | -11 | 6 | -13 | -19 | 3 |
Minority Interest | 0 | 0 | -3 | -4 | -1 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 91 | -2 | 3 | -19 | 47 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 91 | -2 | 5 | -16 | 48 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 101 | 30 | 9 | -24 | 56 |
Depreciation & Amortization (Cash Flow) | 27 | 24 | 16 | 15 | 8 |
Income After Depreciation & Amortization | 74 | 6 | -8 | -39 | 48 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 39.22 | 37.84 | 37.88 | 35.77 | 36.27 |
Diluted EPS Before Non-Recurring Items | 2.09 | 0.16 | 0.69 | 0.11 | 0.98 |
Diluted Net EPS (GAAP) | 2.32 | -0.05 | 0.14 | -0.44 | 1.34 |
Fiscal Year end for Penumbra, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | 12/31/22 | |
---|---|---|---|---|---|
Sales | 284.68 | 270.95 | 261.50 | 241.40 | 221.22 |
Cost Of Goods | 97.69 | 93.23 | 94.64 | 90.33 | 82.79 |
Gross Profit | 186.99 | 177.72 | 166.86 | 151.07 | 138.43 |
SG&A, R&D, and Dept/Amort Expenses | 151.96 | 165.09 | 148.98 | 143.07 | 133.59 |
Income After SG&A, R&D, and Dept/Amort Expenses | 35.03 | 12.63 | 17.88 | 8.00 | 4.84 |
Non-Operating Income | 3.58 | 0.68 | 1.65 | 0.64 | 2.30 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | 38.16 | 13.30 | 19.54 | 8.65 | 7.13 |
Income Taxes | -16.06 | 4.09 | 0.58 | 0.09 | 3.25 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 54.22 | 9.21 | 18.96 | 8.56 | 3.88 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 54.22 | 9.21 | 18.96 | 8.56 | 3.88 |
Earnings Per Share Data | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | 12/31/22 |
---|---|---|---|---|---|
Average Shares | 39.29 | 39.22 | 39.20 | 39.08 | 38.90 |
Diluted EPS Before Non-Recurring Items | 0.76 | 0.67 | 0.43 | 0.23 | 0.16 |
Diluted Net EPS (GAAP) | 1.39 | 0.23 | 0.48 | 0.22 | 0.11 |